Maryam Valapour
@mvalapour
Outcomes researcher. Interests include lung transplant, public policy, and organ allocation. Tweets are my own.
ID: 1141096233966231553
18-06-2019 21:31:57
98 Tweet
143 Followers
103 Following
🎙️July #JHLTThePodcast is live!🎙️ 1⃣ Paulino Alvarez on #BariatricSurgery in #LVAD patients 2⃣ Maryam Valapour and Erika Lease on incorporating long-term survival in the US #LungTx #Allocation system Hear it all at thejhlt.libsyn.com or subscribe on Apple, Spotify, or elsewhere.
On #WorldLungDay, SRTR breaks down #lungtransplant numbers: #transplantation #transplant #lung #LungHealth #RespiratoryInfections .American Lung Association
Important work by Carli Lehr that, as the accompanying editorial by Drs. Ayodeji Adegunsoye and Milda Saunders at UChicago Medicine discuss so eloquently, asks more questions than it answers. jamanetwork.com/journals/jaman…
Great Invited Expert Opinion in #JTCVS comparing longevity of patients with cystic fibrosis in the US vs Canada. By Dr Joel Cooper et al: doi.org/10.1016/j.jtcv… AATS CTSurgSocMedNetwork Maryam Valapour Marcelo Cypel Plus a Commentary by Harris, Matthew Hartwig et al: doi.org/10.1016/j.jtcv…
New 🇺🇸 data demonstrates higher than previously reported waitlist mortality for 🫁#transplant candidates supported with ECMO. Important work by @CarliLehrMDPhD & Maryam Valapour ⬇️⬇️⬇️⬇️ sciencedirect.com/science/articl…
Congrats Sumita Khatri !! ❤️❤️❤️
Great session on complications in lung transplant @CarliLehrMDPhD @lorenzozaffiri AmericanTransplantCongress #ATC2023SanDiego
" ... racial differences in post-transplant outcomes still exist and must be studied further to achieve improved #equity in the U.S. #transplant system," @CarliLehrMDPhD, at Cleveland Clinic, told Healio. bit.ly/46VrEor
Higher utilization of ECMO bridge to transplant and increased waitlist mortality found using newly collected OPTN/UNOS data. Continued efforts are needed to ensure timely access to transplant for this population. @CarliLehrMD Maryam Valapour 🔗: jhltonline.org/article/S1053-…
Is there a better way to capture waitlist mortality risk for #LungTx patients? Using clinically-interpretable dimensions leads to improved phenotyping and better understanding of mortality risk. @CarliLehrMDPhD Maryam Valapour Jarrod Dalton 🔗jhltonline.org/article/S1053-…
The cost of end-of-life hospitalizations for lung disease varies widely, averaging $29,981 per patient; this raises the question of whether lung transplantation could avert acute care costs for some patients. @CarliLehrMDPhD Jarrod Dalton Maryam Valapour brnw.ch/21wH5mS